Gad Abraham

Dr Gad Abraham is a Senior Scientist with CSL Research at the Bio21 Institute, where he is leading the application of human genetics to support the company’s drug development pipeline. Previously he had worked in academia on developing polygenic risk scores for a range of cardiovascular and autoimmune diseases, as well as development of methods and tools for analysis of large-scale genetic and multi-omic data.